Why Sana Biotechnology Shares Are Rising Today
Sana Biotechnology, Inc. (NASDAQ: SANA) announced the U.S.
Mental Health Treatment: Compass Pathways And Greenbrook TMS Join Forces For Psilocybin Therapy Research
Biotechnology company Compass Pathways plc (NASDAQ: CMPS) and Greenbrook TMS Inc (NASDAQ: GBNH) have entered into a three-year research collaboration agreement to explore delivery models
Why Is Lung Disease Focused Theravance Biopharma Stock Trading Lower Today?
Theravance Biopharma Inc (NASDAQ: TBPH) announced results from the Phase 4 PIFR-2 study of Yupelri (revefenacin) inhalation solution, the only once-daily, nebulized long-acting muscarinic antagonist (LAMA) approved in the U.S.
Why Biopharmaceutical Player CureVac Shares Are Rising Today
CureVac N.V. (NASDAQ: CVAC) shares are trading higher on Friday.
With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs
Key Takeaways:
AstraZeneca will acquire Chinese cell therapy maker Gracell for up to $1.2 billion, representing an 86% premium to the company’s pre-announcement share price
The Bull Case for Hawkins Inc. (NASDAQ: HWKN)
With Quiver Quantitative’s recent institutional holdings data, we can see that hedge funds and asset managers have been increasing their holdings in Hawkins Inc. (NASDAQ: HWKN).
Greenbrier Posts Upbeat Earnings, Joins Kura Sushi USA, AxoGen And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones index gaining more than 100 points on Friday.
Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply during Friday’s session following upbeat earnings.
Nurturing Growth: Caleres Supports Investors with Growing Earnings
At the end of January 05, 2024, Caleres (NYSE:CAL) will reward its shareholders with a dividend payout of $0.07 per share, demonstrating an annualized dividend yield of 1.00%. Remember, only investors who held the stock before the ex-dividend date on December 20, 2023 will receive this payout.
Why Catalyst Pharmaceuticals Stock Is Trading Lower
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) shares are trading lower by 13% to $14.89 Friday morning.
Cramer Says This ‘Inexpensive’ Stock Is ‘Doing Some Great Things With Aerospace’
Jim Cramer said WK Kellogg Co (NYSE: KLG) doesn’t have a "lot of growth, and it doesn’t have a lot of yield." He prefers Kellanova (NYSE: K)